Literature DB >> 26191149

MiRNA-139 regulates oral cancer Tca8113 cells apoptosis through Akt signaling pathway.

Youzhong Ren1, Hongguang Zhu2, Chunyuan Chi1, Fanghong Yang1, Xin Xu3.   

Abstract

Oral cancer threats people's life and health seriously. Traditional treatment (surgery, radiotherapy, chemotherapy and traditional Chinese medicine treatment) is lack of pertinence that affects curative effect and prognosis. Therefore, it is necessary to explore the specific targets for oral cancer treatment. MiRNA-139 was transfected into oral cancer Tca8113 cells. Methyl thiazolyl tetrazolium (MTT) was applied to test cell proliferation. Flow cytometry was used to detect oral cancer Tca8113 cells apoptosis. miR-139 significantly inhibits oral cancer Tca8113 cells proliferation and induces cell apoptosis. SH-5 obviously weakened the cell apoptosis caused by miR-139. miR-139 could induce Tca8113 cell apoptosis through Akt signaling pathway. It may develop a more effective method for oral cancer treatment by this target.

Entities:  

Keywords:  Akt signaling pathway; Tca8113; apoptosis; miR-139

Mesh:

Substances:

Year:  2015        PMID: 26191149      PMCID: PMC4503021     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Coadministrating luteolin minimizes the side effects of the aromatase inhibitor letrozole.

Authors:  Fengjuan Li; Tsz Yan Wong; Shu-mei Lin; Simon Chow; Wing-hoi Cheung; Franky L Chan; Shiuan Chen; Lai K Leung
Journal:  J Pharmacol Exp Ther       Date:  2014-08-19       Impact factor: 4.030

2.  miR-21-mediated tumor growth.

Authors:  M-L Si; S Zhu; H Wu; Z Lu; F Wu; Y-Y Mo
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

3.  Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival.

Authors:  Tao Li; Jikai Yin; Lijuan Yuan; Shouli Wang; Lin Yang; Xilin Du; Jianguo Lu
Journal:  Oncol Rep       Date:  2014-02-19       Impact factor: 3.906

4.  Transport and Golgi organisation protein 1 is a novel tumour progressive factor in oral squamous cell carcinoma.

Authors:  Tomonori Sasahira; Tadaaki Kirita; Kazuhiko Yamamoto; Nobuhiro Ueda; Miyako Kurihara; Sayako Matsushima; Ujjal K Bhawal; Anja Katrin Bosserhoff; Hiroki Kuniyasu
Journal:  Eur J Cancer       Date:  2014-06-02       Impact factor: 9.162

Review 5.  Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.

Authors:  Flávia Andressa Pidone Ribeiro; Juliana Noguti; Celina Tizuko Fujiyama Oshima; Daniel Araki Ribeiro
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

6.  Licochalcone A as a potent antitumor agent suppresses growth of human oral cancer SCC-25 cells in vitro via caspase-3 dependent pathways.

Authors:  Guang Zeng; Huan Shen; Yongjin Yang; Xingwei Cai; Wenxing Xun
Journal:  Tumour Biol       Date:  2014-04-02

7.  3,3',4', 5'-Tetramethoxychalcone inhibits human oral cancer cell proliferation and migration via p53-mediated mitochondrial-dependent apoptosis.

Authors:  Cheng-Kuo Lai; Yerra Koteswara Rao; Kai-Ruei Chang; Cheng-Wen Lin; Hong-Lin Su; Chia-Shuo Chang; Chih-Ho Lai; Yew-Min Tzeng
Journal:  Anticancer Res       Date:  2014-04       Impact factor: 2.480

8.  Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.

Authors:  Wuliji Saiyin; Dali Wang; Lili Li; Lijuan Zhu; Bing Liu; Lijian Sheng; Yanwu Li; Bangshang Zhu; Limin Mao; Guolin Li; Xinyuan Zhu
Journal:  Mol Pharm       Date:  2014-04-04       Impact factor: 4.939

9.  Porphyromonas gingivalis-induced autophagy suppresses cell proliferation through G1 arrest in oral cancer cells.

Authors:  Tae Jin Cho; Shin Wook Wee; Vok Hee Woo; Jeom Il Choi; Seung Jo Kim; Hong In Shin; Ji Hye Lee; Hae Ryoun Park
Journal:  Arch Oral Biol       Date:  2014-01-09       Impact factor: 2.633

10.  Selective apoptotic cell death effects of oral cancer cells treated with destruxin B.

Authors:  Rosa Huang Liu; Shih-Pin Chen; Tsong-Ming Lu; Wei-Yu Tsai; Chung-Hung Tsai; Chi-Chiang Yang; Yew-Min Tzeng
Journal:  BMC Complement Altern Med       Date:  2014-06-28       Impact factor: 3.659

View more
  12 in total

1.  Effects of microRNA-139 on myocardial cell injury induced by oxidative stress.

Authors:  Tao Li; Sumei Liang; Yuxiu Zhang; Yongqing Chen
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.

Authors:  Min Cao; Lijuan Zheng; Jianzhou Liu; Thomas Dobleman; Shen Hu; Vay Liang W Go; Ge Gao; Gary Guishan Xiao
Journal:  Clin Oral Investig       Date:  2018-01-03       Impact factor: 3.573

3.  Pichia fermentans originates apoptosis in human oral squamous cell carcinoma by over-expressing BAX and CASP 9 genes.

Authors:  Hasan Bagherpour Shamloo; Arman Shahabi; Zahra Aghazadeh; Ahmad Yari Khosroushahi
Journal:  Cytotechnology       Date:  2020-04-06       Impact factor: 2.058

4.  Inferring novel genes related to oral cancer with a network embedding method and one-class learning algorithms.

Authors:  Lei Chen; Yu-Hang Zhang; Guohua Huang; Xiaoyong Pan; Tao Huang; Yu-Dong Cai
Journal:  Gene Ther       Date:  2019-08-27       Impact factor: 5.250

5.  MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression.

Authors:  Ying Ye; Juhua Zhuang; Guoyu Wang; Saifei He; Jing Ni; Wei Xia
Journal:  Oncol Lett       Date:  2017-10-17       Impact factor: 2.967

6.  miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.

Authors:  Tong Wang; Yipeng Ren; Ruixun Liu; Juntao Ma; Yueyi Shi; Lei Zhang; Rongfa Bu
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

7.  Construction and analysis of a lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in oral cancer.

Authors:  Junhao Yin; Xiaoli Zeng; Zexin Ai; Miao Yu; Yang'ou Wu; Shengjiao Li
Journal:  BMC Med Genomics       Date:  2020-06-22       Impact factor: 3.063

8.  MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2.

Authors:  Qiaoling Pan; Lebo Sun; Dawei Zheng; Ni Li; Huoshun Shi; Jie Song; Guofeng Shao; Guodong Xu
Journal:  Biomed Res Int       Date:  2018-08-05       Impact factor: 3.411

9.  miR‑148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑G expression.

Authors:  Yuying Zhang; Xin Jin; Jie Wang
Journal:  Mol Med Rep       Date:  2019-05-22       Impact factor: 2.952

10.  MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition.

Authors:  Yuanyuan Kang; Ying Zhang; Yan Sun; Yan Wen; Fuli Sun
Journal:  Onco Targets Ther       Date:  2018-09-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.